NCT02257957View on ClinicalTrials.gov

Platelet -Rich Plasma (PRP) Injection for the Treatment of Severe Dry Eye

PHASE3CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

September 30, 2015

Study Completion Date

April 20, 2016

Conditions
Dry EyeSjogren Syndrome
Interventions
DRUG

PRP injection

DRUG

Standard care Hyaluronic acid eye drops

: 15 patients with diagnosis of severe dry eye will receive standard of care treatment ( Hyaluronic acid eye drops 5 times per day). Objective measurements as corneal staining, Shirmer , BUT, and VA, will be determinate as subjective measurements as OSDI and treatment compliance will be evaluated at day 0-30,60 and 90

All Listed Sponsors
lead

Universidad Nacional de Colombia

OTHER

NCT02257957 - Platelet -Rich Plasma (PRP) Injection for the Treatment of Severe Dry Eye | Biotech Hunter | Biotech Hunter